SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000029905-18-000006
Filing Date
2018-01-30
Accepted
2018-01-30 14:21:21
Documents
1
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5647
  Complete submission text file 0000029905-18-000006.txt   7878
Mailing Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368
Business Address BAYERWERK, GEBAEUDE W11 KAISER-WILHELM-ALLEE LEVERKUSEN 2M D-51368 492143081933
BAYER AKTIENGESELLSCHAFT (Reporting) CIK: 0001144145 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 18558458
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address C/O CRISPR THERAPEUTICS AG 200 SIDNEY STREET CAMBRIDGE MA 02139 617-315-4600
Bayer Global Investments B.V. (Reporting) CIK: 0001685417 (see all company filings)

State of Incorp.: XX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 18558457